The aim of the Bulbar Committee is to investigate and understand the pathology, clinical implications and best treatment strategies of Bulbar MND, including the development of speech and swallowing biomarker parameters throughout disease progression. The committee is chaired by Gary Pattee, MD, from Neurology Associates. 

Recent Bulbar ALS Publications: